drugset / Trial / NCT05327556

Epinephrine in the Pediatric Intensive Care Unit: A Dose-Effect Trial

NCT05327556

RandomizedParallel-groupTriple-blindTreatment

Summary

The use of peri-arrest bolus epinephrine (PBE) has emerged as a rescue strategy for life-threatening hypotension in pediatric intensive care units (ICU) despite scant published data supporting its use in this setting. As optimal dosing of PBE in this population is unclear, we aim to determine if an initial dose of 0.5 mcg/kg versus 1.0 mcg/kg yields differences in hemodynamic outcomes. The EPI Dose Study is a single-center, prospective, randomized, double-blind, dose-effect trial measuring systolic blood pressure (SBP) before and after PBE is given. We hypothesize that the 1.0 mcg/kg group will have more robust increases in SBP.

Timeline

Start
2023-02-08
Primary completion
2025-05-16
Completion
2025-05-16

Drugs

EvaluationDrugModalityDoseRoute
Comparator Epinephrine Other / unclassified 0.5 ug/kg
Comparator Epinephrine Other / unclassified 1 ug/kg

Indications